Skip to content
Chemistry, epigenetics and drugs episode artwork

Jul 28, 2015 3 min

Chemistry, epigenetics and drugs

from Translational and Clinical

Alteration of gene expression is fundamental to many diseases. A better understanding of how epigenetic proteins affect diseases provides a starting point for therapy development and the discovery of new drug. Professor Paul Brennan research focusses on epigenetics: the mechanisms that control gene expression. He studies how chemical probes interfere with epigenetic enyzmes that can be targeted to treat various diseases. Epigenetics combined with disease biology will ultimately accelerate drug discovery.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Chemistry, epigenetics and drugs

0:00 3:57

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Translational and Clinical?

This episode is 3 minutes long.

When was this Translational and Clinical episode published?

This episode was published on July 28, 2015.

Can I download this Translational and Clinical episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.